The results showed that the genes related to the pathogenesis and progression of pancreatic cancer, such as AKT2, TGFBR2, RAF1, TP53, and ERBB2, would be greatly affected by alterations in PPPcs. This evidence concerns the gene TP53 and familial pancreatic carcinoma.